Attention Deficit Disorder With HyperactivityNCT00745524
Screening for Attention-deficit/Hyperactivity Disorder (ADHD) in Adolescent and Adult High Risk Populations
An observational study of Attention Deficit Disorder With Hyperactivity, run by National Taiwan University Hospital at 2 sites in Taiwan.
Trial summary
This study aims to investigate the prevalence of ADHD and other psychopathology, and current function and life quality among several high risk populations of imprisoned adults and adolescents who receive special resources in school or dropout from school. Read more about this study
- Who is it for?
- Ages 13 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Attention Deficit Disorder With Hyperactivity
- How many people
- 1,910 participants
- Where
- 2 sitesTaiwan
- Study dates
- Feb 2008to Dec 2009
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 13 to 65 years
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: Imprisoned adults; adolescents with problems in school and followed by three private charitable organizations; community sample
Who may be able to join
- The adult subjects aged 20~65 form National Tainan Prison are recruited.
- The adolescent subjects aged 13~19, drop out from school or receiving special services, followed by three private charitable organizations are recruited.
- The controls will be recruited according to the structure of sex and age of the cases.
Who cannot join
- In the major depressive episode, comorbid with severe anxiety disorders or during substance intoxication or withdrawal, or during the acute psychotic episode at the time of evaluation.
- With neurodegenerative disorder, epilepsy, involuntary movement disorder, congenital metabolic disorder, brain tumor, history of severe head trauma, and history of craniotomy.
Trial locations and contacts
2 sites in 1 country.
Taiwan2 sites
National Tainan Prison
Tainan, 71150
Tainan Family Educational Center
Tainan, 730
About this study
This study aims to investigate the prevalence of ADHD and other psychopathology, and current function and life quality among several high risk populations of imprisoned adults and adolescents who receive special resources in school or dropout from school.
Read the detailed description
Attention-deficit/hyperactivity disorder (ADHD) is a common (5-10%) childhood-onset neuropsychiatric disorder worldwide among children and adolescents with 50- 60% persistence to adulthood (3-4%). Individuals with ADHD have been reported to have higher risk of school failure, conduct problems, antisocial behaviors, legal problems, substance use problems and other psychiatric comorbidities, and face many difficulties of the interpersonal relationship, occupation and family in every day life. Despite plenty of researches reported in the west countries, we have limited information in Taiwan about adult ADHD and the associated impact on the function and quality of life of the affected individuals. For the perspective of public health, it's mandatory to collect information from the high risk populations of ADHD for further policy establishment to prevent further impact on individuals, families, and society in Taiwan.
This study target on two populations: (1) imprisoned adults (2) adolescents with problems in school and followed by three private charitable organizations. Each population is assessed by the instruments for ADHD symptoms (ASRS and SNAP-IV), psychopathology (ASRI and/or YSR and CBCL), and academic/social/occupational /family function (WFIRS-S, WFIRS-P). Adult population is also checked for the quality of life (AAQoL). We will recruit the community-based controls matching with sex and age is assessed with the same instruments.
We anticipate that this study will provide the primitive data on the prevalence of ADHD and other psychopathology, academic/occupational/social/family function, quality of life of adolescent and adult patients in the high risk populations, will evaluate the difference between adults in prison, adolescents dropping out from school, and their community controls with regards to symptomatology, quality of life, and function; and young psychiatric researchers will learn to collect data, conduct statistical analysis, and prepare the manuscript. Our findings should have clinical implication in assessing adults and adolescents at high risk of ADHD and provide the reference data for future public health policy planning regarding early identification of ADHD at childhood and intervention program to offset the adverse social and academic/occupational sequalae of ADHD.
- Keywords
- Attention-deficit hyperactivity disorder, adolescent, adult, high risk population, functional impairment, quality of life
- Medical subject headings
- Attention Deficit Disorder with Hyperactivity
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Sep 2008 (estimated)
- Study startFeb 2008
- Study completionDec 2009
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Attention Deficit Disorder With HyperactivityStudies of the same condition, open and under way.
- More trials run by National Taiwan University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Enrolment
- 1,910 participants (actual)
Sponsor and investigators
- Lead sponsor
- National Taiwan University Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Susan Shur-Fen Gau, MD, PhD, Principal investigator, National Taiwan University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00745524
- Sponsor's protocol ID
- 200801026R
- Status last verified
- Apr 2012
- First submitted
- 31 Aug 2008
- Last updated
- 17 May 2012
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 17 May 2012. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Screening for Attention-deficit/Hyperactivity Disorder (ADHD) in Adolescent and Adult High Risk Populations
- ClinicalTrials.gov ID
- NCT00745524
- Acronym / sponsor ID
- 200801026R
- Keywords
- Attention-deficit hyperactivity disorder, adolescent, adult, high risk population, functional impairment, quality of life
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1,910 participants (actual)
- Lead sponsor
- National Taiwan University HospitalUniversity, hospital or other
- Study start
- Feb 2008
- Study completion
- Dec 2009 (actual)
- First posted
- 3 Sep 2008 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to investigate the prevalence of ADHD and other psychopathology, and current function and life quality among several high risk populations of imprisoned adults and adolescents who receive special resources in school or dropout from school.
Detailed description
Attention-deficit/hyperactivity disorder (ADHD) is a common (5-10%) childhood-onset neuropsychiatric disorder worldwide among children and adolescents with 50- 60% persistence to adulthood (3-4%). Individuals with ADHD have been reported to have higher risk of school failure, conduct problems, antisocial behaviors, legal problems, substance use problems and other psychiatric comorbidities, and face many difficulties of the interpersonal relationship, occupation and family in every day life. Despite plenty of researches reported in the west countries, we have limited information in Taiwan about adult ADHD and the associated impact on the function and quality of life of the affected individuals. For the perspective of public health, it's mandatory to collect information from the high risk populations of ADHD for further policy establishment to prevent further impact on individuals, families, and society in Taiwan.
This study target on two populations: (1) imprisoned adults (2) adolescents with problems in school and followed by three private charitable organizations. Each population is assessed by the instruments for ADHD symptoms (ASRS and SNAP-IV), psychopathology (ASRI and/or YSR and CBCL), and academic/social/occupational /family function (WFIRS-S, WFIRS-P). Adult population is also checked for the quality of life (AAQoL). We will recruit the community-based controls matching with sex and age is assessed with the same instruments.
We anticipate that this study will provide the primitive data on the prevalence of ADHD and other psychopathology, academic/occupational/social/family function, quality of life of adolescent and adult patients in the high risk populations, will evaluate the difference between adults in prison, adolescents dropping out from school, and their community controls with regards to symptomatology, quality of life, and function; and young psychiatric researchers will learn to collect data, conduct statistical analysis, and prepare the manuscript. Our findings should have clinical implication in assessing adults and adolescents at high risk of ADHD and provide the reference data for future public health policy planning regarding early identification of ADHD at childhood and intervention program to offset the adverse social and academic/occupational sequalae of ADHD.
Study design
- Observational model
- Case-control
Who may qualify
- Ages
- 13 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Imprisoned adults; adolescents with problems in school and followed by three private charitable organizations; community sample
Key inclusion criteria (3 listed)
- The adult subjects aged 20~65 form National Tainan Prison are recruited.
- The adolescent subjects aged 13~19, drop out from school or receiving special services, followed by three private charitable organizations are recruited.
- The controls will be recruited according to the structure of sex and age of the cases.
Key exclusion criteria (2 listed)
- In the major depressive episode, comorbid with severe anxiety disorders or during substance intoxication or withdrawal, or during the acute psychotic episode at the time of evaluation.
- With neurodegenerative disorder, epilepsy, involuntary movement disorder, congenital metabolic disorder, brain tumor, history of severe head trauma, and history of craniotomy.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 May 2012.
Related trials for Attention Deficit Disorder With Hyperactivity
RecruitingObservational study
Psychotherapy for Irritability in Youth: Comparing Active Treatment to Nonactive Psychoeducation Supportive Psychotherapy
Irritability, Disruptive Mood Dysregulation Disorder
RecruitingObservational study
Augmenting Parent Management Training for Child Temper Outbursts Using a Digital Tool
Disruptive Behavior Disorders, Conduct Disorder
RecruitingPhase 2
A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)
Attention Deficit Disorder With Hyperactivity (ADHD)
Not yet recruiting
QAIAx - SGI/SI Smart Health Cities: Microcity Enclave Program (Quantum SI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360; USPTO EO 9424 Assignment ID: 2101042 / ARN: REEL/FRAME: 76481/0026 - OUSD-R&E, Department of War)
Asperger's Disorder, Asperger Disorder
RecruitingObservational study
Pharmacogenomics of Stimulant Treatment Response
Attention-Deficit/ Hyperactivity Disorder (ADHD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Susan Shur-Fen Gau, MD, PhD principal investigator
National Taiwan University Hospital
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Attention Deficit Disorder With Hyperactivity, run by National Taiwan University Hospital at 2 sites in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 May 2012. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 May 2012.